Levodopa responsive hemidystonia associated with contralateral nigral lesion.
Lyoo
Chul Hyoung
CH
Lee
Myung Sik
MS
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001927:Brain Diseases / Q000150:complications / Q000473:pathology*; D004421:Dystonia / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D007839:Functional Laterality; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D049268:Positron-Emission Tomography / Q000379:methods; D013378:Substantia Nigra / Q000000981:diagnostic imaging / Q000473:pathology*; D014326:Tropanes
D018726:Anti-Dyskinesia Agents; D014326:Tropanes; C087552:2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane; D007980:Levodopa